对耐火性光盘性狼治疗的阿尼弗罗卢马布:在沙特阿拉伯,有两份成功治疗结果的病例报告
相关实验视频
Updated: Jun 13, 2025

05:38
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
36
1Department of Medicine, College of Medicine, Taibah University, Medina, Saudi Arabia.
Medicine
|May 19, 2025
概括
阿尼弗罗卢马布在治疗光盘性红斑狼 (DLE),一种痕性皮肤疾病方面表现有前途. 这种新疗法迅速改善了症状,并减少了两名耐药DLE患者的类固醇使用.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 迪斯科性红斑狼 (DLE) 是一种慢性,痕性皮肤疾病,治疗选择有限.
- 耐火性DLE导致显著的心理痛苦和治疗阻力.
- 现有的DLE疗法往往无法提供足够的缓解,并可能产生不良影响.
研究的目的:
- 为了评估anifrolumab在耐火性 discoid 红血性狼患者的疗效.
- 评估anifrolumab在改善DLE症状和减少皮质类固醇依赖方面的潜力.
主要方法:
- 两名耐火性DLE患者每月接受静脉静脉注射阿尼弗罗卢马布 (300毫克) 结合基和甲醇.
- 临床结局使用皮肤性狼红斑性疾病区域和严重性指数-活动 (CLASI-A) 评分来评估.
- 对患者的反应和不良事件进行了监测.
主要成果:
- 两位患者在第一次服用阿尼弗罗卢马布剂量后都出现了显著的症状改善,包括减少病变,红血和.
- 在这两位患者中都观察到可见的头发再生.
- 克拉西-A分数显著改善 (从18到3和8到1),使得一个患者可以停止使用皮质类固醇. 没有报告任何不良影响.
结论:
- 阿尼弗罗卢马布显示出作为耐火性DLE有效治疗的潜力.
- 这种疗法可以快速和持续地改善疾病活动和生活质量.
- 在具有挑战性的DLE病例中,阿尼弗罗卢马布可能会减少皮质类固醇依赖,这需要进一步调查.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145

